• Patients Adhere Well to CFTR Therapies But High Costs Could Undermine Use, Pharmacy Study Says
  • Vertex Reaches Agreement for CF Medications in Northern Ireland and Wales
  • Rare Disease Film Festival Highlights Patient and Researcher Unity
  • Inspiration for Hire: Sick Candidates Only
  • Proteostasis Therapeutics Completes Enrollment in Phase 2 Study Testing Triple Combination Therapy in Cystic Fibrosis
  • Latinos on 2 Caribbean Islands Carry CFTR Mutations Seen in 1% of CF Patients Elsewhere, Study Says
  • Addressing the Issues that Trikafta Benefits Will Bring
  • Bionic Pancreas May Be Useful in Managing Blood Sugar Levels in Adults with CFRD, Small Study Says
  • Eloxx Presents Positive Preclinical and Clinical Data of CF Therapy Candidate ELX-02
  • Preclinical Data Supports Effectiveness of ARO-ENaC, Arrowhead’s Investigational Therapy for CF
  • Two New CFTR Gene Variants Identified in Young CF Patients, Study Reports
  • What We Should Expect from the CF Foundation’s ‘Path to a Cure’
Average Rating
0 out of 5 stars. 0 votes.
My Rating: